Abstract:Aims Inflammation is central to the pathogenesis of metabolic syndrome (MetS). Leukocyte cell-derived chemotaxin 2 (LECT2) is constitutively secreted in response to inflammatory stimuli and oxidative stress contributing to tissue or systemic inflammation. We explored the relationship between LECT2 levels and MetS severity in humans and mice. Methods Serum LECT2 levels were measured in 210 participants with MetS and 114 without MetS (non-MetS). LECT2 expression in the liver and adipose tissue was also examined in mice fed a high-fat diet (HFD) and genetically obese (ob/ob) mice. Results Serum LECT2 levels were significantly higher in MetS participants than in non-MetS participants (7.47[3.36–17.14] vs. 3.74[2.61–5.82], P < 0.001). Particularly, serum LECT2 levels were significantly elevated in participants with hypertension, central obesity, diabetes mellitus (DM), hyperglycaemia, elevated triglyceride (TG) levels, and reduced high-density lipoprotein cholesterol (HDL-C) levels compared to those in participants without these conditions. Pearson's correlation analysis showed that serum LECT2 levels were positively associated with conventional risk factors in all patients. Moreover, LECT2 was positively associated with the number of MetS components ( r = 0.355, P < 0.001), indicating that higher serum LECT2 levels reflected MetS severity. Multivariate regression analysis revealed that a one standard deviation increase in LECT2 was associated with an odds ratio of 1.52 (1.01–2.29, P = 0.044) for MetS prevalence after adjusting for age, sex, body mass index, waist circumference, smoking status, white blood cell count, fasting blood glucose, TG, total cholesterol, HDL-C, blood urea nitrogen, and alanine aminotransferase. Receiver operating characteristic curve analysis confirmed the strong predictive ability of serum LECT2 levels for MetS. The optimum serum LECT2 cut-off value was 9.05. The area under the curve was 0.73 (95% confidence interval 0.68–0.78, P < 0.001), with a sensitivity and specificity of 45.71% and 95.61%, respectively. Additionally, LECT2 expression levels were higher at baseline and dramatically enhanced in metabolic organs (e.g. the liver) and adipose tissue in HFD-induced obese mice and ob/ob mice. Conclusions Increased LECT2 levels were significantly and independently associated with the presence and severity of MetS, indicating that LECT2 could be used as a novel biomarker and clinical predictor of MetS.

Inverse Relationship Between Serum Lipoxin A4 Level And The Risk Of Metabolic Syndrome In A Middle-Aged Chinese Population

Positive Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population.

Quantitative Relationship Between Liver Fat Content and Metabolic Syndrome in Obese Children and Adolescents.

Association Between Lipoprotein (a) Levels and Metabolic Syndrome in a Middle-aged and Elderly Chinese Cohort.

Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese

Circulating fractalkine levels predict the development of the metabolic syndrome.

Plasma Signature Metabolites of Dietary Fat Intake Characterize Associations with Prevalent Metabolic Syndrome

The Correlation Between Serum Uric Acid Level and Abdominal Obesity or Metabolic Syndrome

A panel of free fatty acid ratios to predict the development of metabolic abnormalities in healthy obese individuals

Independent and Opposite Associations of Trunk and Leg Fat Depots with Adipokines, Inflammatory Markers, and Metabolic Syndrome in Middle-Aged and Older Chinese Men and Women

Truncal and Leg Fat Associations with Metabolic Risk Factors among Chinese Adults.

Higher Serum Carotenoid Concentration Associated with A Lower Incidence of Metabolic Syndrome in Middle-Aged and Elderly Chinese Adults

Lymphocyte to High-Density Lipoprotein Ratio but Not Platelet to Lymphocyte Ratio Effectively Predicts Metabolic Syndrome among Subjects from Rural China.

Lean Body Mass, Interleukin 18, and Metabolic Syndrome in Apparently Healthy Chinese

Enhanced Predictive Value of Lipid Accumulation Product for Identifying Metabolic Syndrome in the General Population of China

The protective effects of lipoxin A4 on type 2 diabetes mellitus: A Chinese prospective cohort study

Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome

453-P: Serum Lipocalcin-2 Levels, Fat Distribution, and the Risk of Cardiovascular Events—A Chinese Community-Based Longitudinal Cohort

Serum Lipocalin-2 Levels Are Positively Associated with Not Only Total Body Fat but Also Visceral Fat Area in Chinese Men

Clinical Surrogate Markers for Predicting Metabolic Syndrome in Middle-Aged and Elderly Chinese.

Associations of plasma very-long-chain SFA and the metabolic syndrome in adults - ERRATUM.